These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3119696)

  • 1. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P; Rocco A; del Pozo E
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D; Lobo RA
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
    Huang HJ; Ishimaru T; Yamabe T
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):265-78. PubMed ID: 3136040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
    Corenblum B; Taylor PJ
    Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Fossati P
    Fertil Steril; 1985 Sep; 44(3):356-60. PubMed ID: 3161758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
    Steingold KA; Lobo RA; Judd HL; Lu JK; Chang RJ
    J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
    Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D; Eckstein N; Avidan S; Eshel A; L'Hermite M; Caufriez A; Spitz I; Zylber-Haran E
    Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.
    Barnes RB; Lobo RA
    J Clin Endocrinol Metab; 1985 Oct; 61(4):779-82. PubMed ID: 3928677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
    Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
    J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.